These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Constitutive type-1 interferons signaling activity in malignant gliomas. Li C; Long L; Wang Y; Chi X; Zhang P; Zhang Y; Ji N J Neurooncol; 2024 Jul; 168(3):381-391. PubMed ID: 38789844 [TBL] [Abstract][Full Text] [Related]
49. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling. Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251 [TBL] [Abstract][Full Text] [Related]
50. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio. Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512 [TBL] [Abstract][Full Text] [Related]
51. Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas. Blanco-Carmona E; Narayanan A; Hernandez I; Nieto JC; Elosua-Bayes M; Sun X; Schmidt C; Pamir N; Özduman K; Herold-Mende C; Pagani F; Cominelli M; Taranda J; Wick W; von Deimling A; Poliani PL; Rehli M; Schlesner M; Heyn H; Turcan Ş Cell Rep Med; 2023 Nov; 4(11):101249. PubMed ID: 37883975 [TBL] [Abstract][Full Text] [Related]
52. Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer. Handa Y; Tsutani Y; Shiroma N; Kai Y; Mimae T; Miyata Y; Takeshima Y; Arihiro K; Okada M Clin Lung Cancer; 2020 Jul; 21(4):e302-e314. PubMed ID: 32102750 [TBL] [Abstract][Full Text] [Related]
53. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes. Yang Q; Zhang H; Wei T; Lin A; Sun Y; Luo P; Zhang J Front Immunol; 2021; 12():756722. PubMed ID: 34804043 [TBL] [Abstract][Full Text] [Related]
54. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Zhang C; Li J; Wang H; Song SW Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332 [TBL] [Abstract][Full Text] [Related]
55. The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. Pinton L; Masetto E; Vettore M; Solito S; Magri S; D'Andolfi M; Del Bianco P; Lollo G; Benoit JP; Okada H; Diaz A; Della Puppa A; Mandruzzato S J Immunother Cancer; 2019 Feb; 7(1):58. PubMed ID: 30813960 [TBL] [Abstract][Full Text] [Related]
56. Reoperation in recurrent high-grade gliomas: literature review of prognostic factors and outcome. Brandes AA; Vastola F; Monfardini S Am J Clin Oncol; 1999 Aug; 22(4):387-90. PubMed ID: 10440196 [TBL] [Abstract][Full Text] [Related]
57. The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer. Wu B; Zhao S; Sheng Y; Ren L; Song G Medicine (Baltimore); 2018 Aug; 97(34):e11972. PubMed ID: 30142826 [TBL] [Abstract][Full Text] [Related]
59. Revealing the role of SPP1 Tang W; Lo CWS; Ma W; Chu ATW; Tong AHY; Chung BHY Cell Biosci; 2024 Mar; 14(1):37. PubMed ID: 38515213 [TBL] [Abstract][Full Text] [Related]
60. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment Zha C; Meng X; Li L; Mi S; Qian D; Li Z; Wu P; Hu S; Zhao S; Cai J; Liu Y Cancer Biol Med; 2020 Feb; 17(1):154-168. PubMed ID: 32296583 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]